Financial Year |
March 31 2023 |
Monetary Funds |
1,315,537,985.32 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
1,691,170,251.21 |
Advances to Suppliers |
5,100,941.00 |
Other Receivables |
556,454.39 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
10,111,998.27 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
410,066,478.92 |
Total Current Assets |
3,505,066,090.06 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
14,235,000.00 |
Long-term Equity Investment |
803,702,816.18 |
Investment Properties |
19,142,121.09 |
Fixed Assetes |
14,310,062,500.79 |
Under-construction Projects |
2,520,833,642.65 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
197,848,998.83 |
R&D expenses |
-- |
Goodwill |
18,121,610.82 |
Long-Term Deferred and Prepaid Expenses |
728,448.63 |
Deferred Income Tax Assets |
17,005,642.50 |
Other Non-Current Assets |
28,406,054.42 |
Sub-Total of Non-Current Assets |
17,984,888,164.95 |
Total Assets |
21,489,954,255.01 |
Short-Term Loans |
149,030,899.64 |
Trading Financial liabilities |
-- |
Notes Payable |
54,346,478.01 |
Accounts Payable |
763,076,977.27 |
Accounts Received In Advance |
23,896.68 |
Employee Compensation Payable |
19,122,306.75 |
Taxes Payable |
22,677,204.06 |
Interest Payable |
-- |
Dividend Payable |
2,311,891.82 |
Other payables |
332,825,268.99 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,739,060,519.86 |
Other Current Liabilities |
2,262,545.31 |
Sub-Total of Current Liabilities |
3,082,426,096.57 |
Long-term Loans |
7,836,326,406.62 |
Bonds Payable |
1,007,743,835.61 |
Long-Term Accounts Payable |
191,151,574.72 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
6,011,260.53 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
9,066,864,351.39 |
Total Liabilities |
12,149,290,447.96 |
Paid-In Capital(Or Share Stock) |
1,600,540,535.00 |
Capital Surplus |
4,495,382,810.54 |
Surplus Reserve |
230,824,629.16 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,876,004,658.42 |
Minority Stockholder's Interest |
1,117,826,146.46 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,222,837,660.59 |
Owner's Equity(Stockholder's Equity) |
9,340,663,807.05 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
21,489,954,255.01 |